Alphabet’s (GOOG) (GOOGL) secretive drug discovery arm, Isomorphic Labs, is getting ready to start testing its AI-designed drugs in humans, Colin Murdoch, the company’s president and Google DeepMind’s chief business officer, told Fortune. Born from DeepMind’s AlphaFold breakthrough, Isomorphic Labs is pairing cutting-edge AI with pharma veterans to design medicines faster, cheaper, and more accurately, Fortune’s Beatrice Nolan writes.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GOOGL:
- Kevin O’Leary Says ‘Bitcoin Miners Hold the Blueprint for America’s AI Supremacy’
- Musk to launch new political party, Trump threatens BRICS tariff: Morning Buzz
- 3 Mega Cap Stocks with Potential to Beat the Market, 7/7/25
- Trump Trade: Trump warns of 10% tariff for ‘Anti-American’ BRICS policies
- Alphabet Class A call buyer realizes 5% same-day gains